Last updated: 21-07-2026

What Research and Innovation Initiatives Are Shaping Plant-Based and Hybrid Proteins in Europe?

Ask which research or innovation initiatives are shaping the future of plant-based and hybrid proteins in Europe and you get a fragmented picture: Horizon EU projects, national programmes, industry consortia, and a fresh policy layer since the EU Protein Action Plan arrived in July 2026. This article maps the initiatives that matter — and the €3 billion agenda that connects them.

What is the current baseline of European protein R&I funding?

Between January 2020 and April 2024, European public and non-profit investment in plant-based research and innovation totalled close to €400 million, according to the Good Food Institute Europe (GFI, 2024). Two thirds of end-product funding targeted meat-like products; crop development received an estimated €100m across public-private partnerships.

The Good Food Institute Europe mapping is the reference dataset for anyone sizing the field. It shows a research system weighted toward meat analogues (66% of end-product focus) and dairy-like products (27%), with crop development split between the European Commission (€56m) and member states — the Nordics, DACH region, and France-Spain-Portugal leading. The gap it reveals: consumer research, health evidence, and hybrid-specific formulation remain underfunded relative to their commercial weight.

Which EU-level programmes carry the agenda?

Horizon Europe is the primary vehicle, running projects across fermentation (HealthFerm), dietary transition (Giant Leaps, Plenitude), and protein ingredient functionality (Profuture). Since 07-07-2026, the EU Protein Action Plan adds a dedicated policy framework for protein diversification, connecting research funding to farm-level and market measures.

Horizon EU projects form the connective tissue between universities such as Wageningen University, KU Leuven, and applied institutes including INRAE, VTT, and RISE, and the companies that scale their outputs. Gerard Klein Essink, founder of FoodConNext Foundation, has contributed across several of these consortia — including HealthFerm, Giant Leaps, Plenitude, and Profuture — and presented the innovation investment case at the European Parliament and European Commission in June 2026. That first-hand consortium experience shapes a consistent observation: Europe's research excellence is real, but its translation into shelf-ready hybrid and plant-based products lags because funding pillars rarely talk to each other.

What does The Plant-Based Opportunity agenda propose?

The Plant-Based Opportunity (FoodConNext Foundation, 2025) outlines 75 concrete innovation projects requiring a projected €3 billion between 2026 and 2035 — three times 2020–2024 funding levels — across seven pillars, from consumer engagement (€720m) to sustainable products and circular bioeconomy (€995m).

Developed in consultation with companies and researchers across Plant-Based Foods Europe, the European Alliance for Plant-Based Foods, and EUVEPRO, the agenda is a playbook rather than a wish list: each project carries a budget. Its projected outcome — the plant share of European protein intake rising from 40% to 50% by 2035 — is a forecast, not a commitment, but it anchors the scale of ambition. Two flagship cases matter for hybrid proteins specifically: the Oat4EU roadmap (19 projects scaling oat from breakfast drink to hybrid dairy ingredient) and a proposed European Tofu & Tempeh Research Centre (€25m) for minimally processed categories.

Which initiatives target hybrid proteins directly?

Hybrid-relevant research concentrates in three areas: protein functionality studies comparing plant proteins with casein micelles and whey (for hybrid dairy), texturisation and binding research (for blended meat), and the proposed AlphaFood platform — an open, AlphaFold-style AI model predicting ingredient functionality from origin and processing history.

The €50m Digital Innovation & AI pillar of The Plant-Based Opportunity proposes AlphaFood as a five-step programme: high-throughput ingredient characterisation, standardised data sharing, an AI functionality model, process-chain simulation, and formulation software. For hybrid formulators, this is the initiative to watch — it would compress the trial-and-error cycle that currently makes blending animal and plant proteins expensive. Industry is not waiting: ingredient partners on the Hybrid Foods Europe programme, including Beneo, ADM, Cosun Beet Company, and Crespel & Deiters, run their own application research that the Innovation Plaza puts directly in delegates' hands on 16-09-2026.

How do the initiative types compare?

Where does the agenda go next?

The next phase is coordination: aligning Horizon Europe, the EU Protein Action Plan, member-state programmes, and industry co-investment behind commodity-specific roadmaps — oats first, then soy, pea, faba bean, and sunflower. The open question is whether Europe funds it before the United States and China scale their own sectors.

That coordination question is on the table in Amsterdam. The Hybrid Foods Europe programme closes with an expert panel on the hybrid value chain outlook to 2028, and sessions from ProVeg International and WWF connect the research agenda to retail climate commitments. Companies wanting to partner on the research-to-market bridge can contact FoodConNext Foundation or register for the conference.

Take-home messages

Commercial

• €400m flowed into European plant-based R&I in 2020–2024 (GFI, 2024); the industry agenda projects a €3b need for 2026–2035.

• The EU Protein Action Plan (July 2026) creates a policy hook for co-funded innovation bids.

• Commodity roadmaps (oat first) will steer where public money lands — position your crop and category now.

• Early participation in consortia buys market intelligence years before publication.

  
  

Technical

• Hybrid dairy research hinges on plant protein behaviour versus casein micelles and whey — a named priority in the 2026–2035 agenda.

• Texturisation, binding, and fat-system research (methyl cellulose alternatives, marbling fats) directly serve blended meat.

• AlphaFood-style AI functionality prediction could compress hybrid formulation cycles substantially.

• Rapid legume quality tests (tofu suitability of soybeans, isoflavone screening) are funded priorities under the harmonisation pillar.

  
  

Verdict & next step

The initiatives shaping plant-based and hybrid proteins in Europe are converging on one decade and one number: 75 projects, a projected €3 billion, 2026–2035. The people writing that agenda — researchers, ingredient houses, retailers, and policymakers — meet at Hybrid Foods Europe, 14–16 September 2026, Van der Valk Zuidas, Amsterdam. The funding map is being drawn now, and the room is capacity-limited. Register and help draw it.

About the author

Gerard Klein Essink is Founder and CEO of FoodConNext Foundation. He has run international plant-based foods and proteins communities for more than 20 years, welcoming 10,000+ delegates and 1,250+ speakers across 250+ partner organisations. He authored The Plant-Based Opportunity innovation investment agenda, has advised Protein Industries Canada since 2019, produced strategic outlook reports for Pulse Canada and Australia's GRDC, contributed to Horizon EU projects including HealthFerm, Giant Leaps, Plenitude, and Profuture, and spoke at the European Parliament and European Commission in June 2026.

About FoodConNext Foundation

At FoodConNext Foundation, we believe that the future of food lies at the intersection of innovation, sustainability, and global collaboration. Our foundation is dedicated to accelerating the transition toward more resilient and responsible food systems by connecting key stakeholders across the agri-food ecosystem.

Our Mission

FoodConNext Foundation exists to bridge gaps in the global food system — bringing together entrepreneurs, researchers, policymakers, and investors to co-create solutions that address some of the world's most pressing challenges, including food security, sustainability, and nutrition.